abstract |
The invention relates to thienopyrimidine of the formula (I) as well as to their physiologically acceptable salts, wherein R<1>, R<2>, R<3>, R<4>, X and n have the meaning cited in Claim 1. Said compounds exhibit a phosphodiesterase V inhibition and can be used in the treatment of cardiovascular diseases and for the treatment and/or therapy potency disorders. |